LYEL
Lyell Immunopharma, Inc. Common Stock
stockNASDAQ
At CloseNov 4, 2026 3:59:52 PM EST
15.47USD+43.640%(+4.70)1,100,592
Pre-marketNov 4, 2026 9:27:59 AM EST
12.12USD+12.535%(+1.35)
After-hoursNov 4, 2026 4:59:30 PM EST
15.25USD-1.422%(-0.22)
LYEL Financials
In Q2 FY 2026 (ended ), Lyell Immunopharma, Inc. Common Stock (LYEL) reported revenue of $4K, net income of −$44.76M, operating cash flow of −$33.92M, and assets of $311.15M (filed ).
Loading financial flows…